The role of hyaluronic acid in the management of periodontal disease

Drugs of Today

Volumn 36, Issue SUPPL. C, 2000, Pages 1-20

  Rabasseda, X ^a  

^a Prous Science ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID;

ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; DRUG HALF LIFE; GINGIVITIS; HUMAN; NONHUMAN; PERIODONTAL DISEASE; PERIODONTITIS; REVIEW; TREATMENT OUTCOME;

EID: 0034073656     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Lange, D.E. Parodontologia Nella Pratica Quotidiana. Scienza e Tecnica Dentistica Edizioni Internazionali: Milan 1983.
2. Anatomia ed istologia del parodonto 1. In: Loiaconi, G., Salvato, A. (Eds.). Atlante di Paradontologia. Farmitalia Carlo Erba S.p.A.: Milan 1985, 4-15.
3. Structure and biology of the periodontum. In: Ramfjord, S.P., Ash, M.M. (Eds.). Periodontology and Periodontics. W.B. Saunders Company: Philadelphia 1979, 1-48.
4. Rateitschak, K.H., Wolf, H.F., Hassel, T.M. Color Atlas of Periodontology. Thieme: Stuttgart 1985.
5. Caton, J.G., Lowenguth, R.A. Classification and diagnosis of periobedontal diseases. J Calif Dent Assoc 1993, 21: 23-34.
6. Dahlen, G.G. Black-pigmented Gram-negative anaerobes in periodontitis. Ferns Immunol Med Microbiol 1993, 6: 181-92.
7. Weinberg, M.A. Mouthrinses and control of gingivitis. US Pharm 1995, 20: 30+32+34+3-30+32+34-39.
8. Herrera, E., Bosch, R.J. Desquamative gingivitis. Hypertrophic papillitis. Monogr Dermatol 1995, 8: 92-9.
9. Horning, G.M., Cohen, M.E. Necrotizing ulcerative gingivitis, periodontitis, and stomatitis: Clinical staging and predisposing factors. J Periodontol 1995, 66: 990-8.
10. Yamamoto, K. Studies on periodontal pathogenic proteinases from Porphyromonas gingivalis and host cells. Folia Pharmacol Jpn 1995, 105: 345-55.
11. Jeffcoat, M.K. Prevention of periodontal diseases in adults: Strategies for the future. Prev Med 1994, 23: 704-8.
12. Brinkley, L.L., Vickerman, M.M. The effects of chlorcyclizine-induced alterations of glycosaminoglycans on mouse palatal shelf elevation in vivo and in vitro. J Embryol Exp Morphol 1982, 69: 193-213.
13. Hugoson, A., Koch, G., Bergendal, T. et al. Oral health of individuals aged 3-80 years in Jonkoping, Sweden, in 1973, 1983, and 1993. II. Review of clinical and radiographic findings. Swed Dent J 1995, 19: 243-60.
14. Arnlaugsson, S., Magnusson, T.E. Prevalence of gingivitis in 6-year-olds in Reykjavik, Iceland. Acta Odontol Scand 1996, 54: 247-50.
15. Robinson, RJ. Gingivitis: A prelude to periodontitis? J Clin Dent 1995, 6: 41-5.
16. Murray, M.C., Mooney, J., Kinane, D.F. The relationship between elastase and lactoferrin in healthy, gingivitis and periodontitis sites. Oral Dis 1995, 1: 106-9.
17. Pederson, E.D., Stanke, S.R., Whitener, S.J., Sebastiani, P.T., Lamberts, B.L., Turner, D.W. Salivary levels of α2-macroglobulin, α1-antitrypsin, C-reactive protein, cathepsin G and elastase in humans with or without destructive periodontal disease. Arch Oral Biol 1995, 40: 1151-5.
18. Leont'ev, V.K., Kankanian, A.P. [The local activation of leukocytes and thrombocytes in periodontal diseases: The role of thrombocyte-activating factor]. Stomatologiia Mosk 1996, 75: 26-9.
19. Uitto, V.J., Nieminen, A., Coil, J., Hurttia, H., Larjava, H. Oral fluid elastase as an indicator of periodontal health. J Clin Periodontol 1996, 23: 30-7.
20. Henskens, Y.M., van den Keijbus, P.A., Veerman, E.C. et al. Protein composition of whole and parotid saliva in healthy and periodontitis subjects. Determination of cystatins, albumin, amylase and IgA. J Periodontal Res 1996, 31: 57-65.
21. Brandimarte, F. Hyaluronic acid and periodontopathies. Minerva Stomatol 1973, 17: 140-56.
22. Goldman, H.M., Cohen, D.W. Periodontium. In: Periodontal Therapy. Mosby: Saint Louis 1973, 1-56.
23. Mangkornkarn, C., Steiner, J.C. In vivo and in vitro glycosaminoglycans from human dental pulp. J Endod 1992, 18: 327-31.
24. Tammi, R., Tammi, M., Hakkinen, L., Larjava, H. Histochemical localization of hyaluronate in human oral epithelium using a specific hyaluronate-binding probe. Arch Oral Biol 1990, 35: 219-24.
25. Cortivo, R., De Galateo, A., Haddad, M., Caberlotto, M., Abatangelo, G. Glycosaminoglycans in human normal gingiva and in periodontosis: Biochemical and histological observations. G Stomatol Ortognatodonzia 1986, 5: 69-72.
26. Koochekpour, S., Pilkington, G.J. Hyaluronic acid modulates glioma cell proliferation through its interaction with CD44H in vitro. Oncol Rep 1996, 3: 133-5.
27. Goebeler, M., Kaufmann, D., Brocker, E., Klein, C.E. Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors. J Cell Sci 1996, 109: 1957-64.
28. Stamenkovic, I., Aruffo, A. Hyaluronic acid receptors. Methods Enzymol 1995, 245: 195-216.
29. Koochekpour, S., Pilkington, G.J., Merzak, A. Hyaluronic acid/CD44H interaction induces cell detachment and stimulates migration and invasion of human glioma cells in vitro. Int J Cancer 1995, 63: 450-4.
30. Murakami, S., Saho, T., Asari, A. et al. CD44-hyaluronate interaction participates in the adherence of T-lymphocytes to gingival fibroblasts. J Dent Res 1996, 75: 1545-52.
31. Clark, R.A., Alon, R., Springer, T.A. CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J Cell Biol 1996, 134: 1075-87.
32. Hashimoto Uoshima, M., Hascall, V.C., MacCallum, D.K., Yanagishita, M. Biosynthesis of proteoglycans and hyaluronic acid by rat oral epithelial cells (keratinocytes) in vitro. Arch Biochem Biophys 1995, 316: 724-32.
33. Bartold, P.M. Lipopolysaccharide stimulation of hyaluronate synthesis by human gingival fibroblasts in vitro. Arch Oral Biol 1991, 36: 791-7.
34. Rafi, A., Nagarkatti, M., Nagarkatti, P.S. Hyaluronate-CD44 interactions can induce murine B-cell activation. Blood 1997, 89: 2901-8.
35. Murakami, S., Okada, H. Lymphocyte-fibroblast interactions. Crit Rev Oral Biol Med 1997, 8: 40-50.
36. King, S.R., Hickerson, W.L., Proctor, K.G., Newsome, A.M. Beneficial actions of exogenous hyaluronic acid on wound healing. Surgery 1991, 109: 76-84.
37. Rodgers, K.E., Johns, D.B., Girgis, W., Campeau, J.D., DiZerega, G.S. Reduction of adhesion formation with hyaluronic acid after peritoneal surgery in rabbits. Fertil Steril 1997, 67: 553-8.
38. Beck, D.E. The role of Seprafilm registered bioresorbable membrane in adhesion prevention. Eur J Surg 1997, 163 (Suppl. 577): 49-55.
39. Burns, J.W., Colt, M.J., Burgess, L.S., Skinner, K.C. Preclinical evaluation of Seprafilm registered bioresorbable membrane. Eur J Surg 1997, 163 (Suppl. 577): 40-8.
40. Liguori, V., Guillemin, C., Pesce, G.R, Mirimanoff, P.O., Bernier, J. Double-blind, randomized clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol 1997, 42: 155-61.
41. Gualtieri, G. The action of exogenous hyaluronic acid on the reparative process with solution of continuity and torpid sores. Policlin (Sezion Med) 1970, 77: 96-102.
42. Osher, R.H., Cionni, R.J., Cohen, J.S. Re-forming the fiat anterior chamber with Healon. J Cataract Refractive Surg 1996, 22: 411-5.
43. Caporossi, A., Baiocchi, S., Sforzi, C., Frezzotti, R. Healon GV versus Healon in demanding cataract surgery. J Cataract Refractive Surg 1995, 21: 710-3.
44. Colin, J., Renard, G., Ullern, M., Lablache Combler, M., Richard, C., Trinquand, C. Prospective compari-son of the effects of Biovisc regis-tered and Healonid registered on endothelial cell loss and intraocular pressure in postcataract surgery. J Fr Ophtalmol 1995, 18: 356-63.
45. Colombo, I., Rega, V., Tosi, R., Bertoja, R. Five-year clinical expehence with the use of hyaluronic acid in osteoarthrosis. Riabilitazione 1996, 29: 17-25.
46. Pavelka, K., Vlasakova, V., Vitova, J., Stehlikova, H., Slansky, J. Hyaluronic acid (Hyalgan registered) in the treatment of gonarthrosis. Rheumatologia 1996, 10: 17-21.
47. Adams, M.E., Atkinson, M.H., Lussier, A.J. et al. The role of viscosupplementation with hylan G-F 20 (Synvisc registered) in the treatment of osteoarthritis of the knee: A Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 1995, 3: 213-25.
48. Carrabba, M., Paresce, E., Angelini, M., Re, K.A., Torchiana, E.E.M., Perbellini, A. The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm 1995, 15: 25-31.
49. Corrado, E.M., Peluso, G.E, Gi-gliotti, S. et al. The effects of intraarticular administration of hyaluronic acid on osteoarthritis of the knee: A clinical study with immunological and biochemical evaluations. Eur J Rheumatol Inflamm 1995, 15: 47-56.
50. Formiguera Sala, S., Esteve de Miguel, R. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: A short term study. Eiur J Rheumatol lnflamm 1995, 15: 33-8.
51. Itokazu, M., Matsunaga, T. Clinical evaluation of high-molecular-weight sodium hyaluronate for the treatment of patients with periarthritis of the shoulder. Clin Ther 1995, 17: 946-55.
52. Jones, A.C., Pattrick, M., Doherty, S., Doherty, M. Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Os-teoarthritis Cartilage 1995, 3: 269-73.
53. Maheu, E. Hyaluronan in knee osteoarthritis: A review of the clinical trials with Hyalgan registered. Eur J Rheumatol Inflamm 1995, 15: 17-24.
54. Weigel, P.H., Fuller, G.M., LeBoeuf, R. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol 1986, 119: 219-34.
55. Bartold, P.M. The effect of interleukin-1beta on hyaluronic acid synthesized by adult human gingival fibroblasts in vitro. J Periodontal Res 1988, 23: 139-47.
56. Oksala, O., Salo, T., Tammi, R. et al. Expression of proteoglycans and hyaluronan during wound healing. J Histochem Cytochem 1995, 43: 125-35.
57. Bartold, P.M. Platelet-derived growth factor stimulates hyaluronate but not proteoglycan synthesis by human gingival fibroblasts in vitro. J Dent Res 1993, 72: 1473-80.
58. Irwin, C.R., Schor, S.L., Ferguson, M.W.J. Effects of cytokines on gingival fibroblasts in vitro are modulated by the extracellular matrix. J Periodontal Res 1994, 29: 309-17.
59. Fukuda, K., Takayama, M., Ueno, M. et al. Hyaluronic acid inhibits interleukin-1-induced superoxide anion in bovine chondrocytes. Inflamm Res 1997, 46: 114-7.
60. Zattoni, G., Cabrioli, A., Brunelli, G., Perbellini, A. Efficacy and tolerabilty of hyaluronic acid in acute knee injury: A controlled clinical study. Eur J Rheumatol Inflamm 1995, 15: 63-9.
61. Scali, J.J. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: A long term study. Eur J Rheumatol Inflamm 1995, 15: 57-62.
62. Kondo, M., Nakatani, T. The effect of sodium hyaluronate (ARTZ registered) on the synovium with the osteoarthritis of the knee. Jpn Pharmacol Ther 1995, 23: 163-70.
63. Kolarz, G., Kotz, R., Broll, H. et al. Hyaluronic acid in the treatment of osteoarthritis of the knee joint: Interim results of a comparative clinical study. Eur J Rheumatol lnflamm 1995, 15: 39-45.
64. Di Marco, C., Letizia, G.A. Hyaluronic acid in the treatment of pain due to knee joint immobilisation. A controlled clinical study. Clin Drug Invest 1995, 10: 191-7.
65. Kopp, S., Wenneberg, B., Harald-son, T., Carlsson, G.E. The short-term effect of intra-articular injections of sodium hyaluronate and corticosteroid on temporomandibular joint pain and dysfunction. J Oral Maxillofac Surg 1985, 43: 429-35.
66. Kopp, S., Carlsson, G.E., Haraldson, T., Wenneberg, B. Long-term effect of intra-articular injections of sodium hyaluronate and corticosteroid on temporomandibular joint arthritis. J Oral Maxillofac Surg 1987, 45: 929-35.
67. Bertolami, C.N., Gay, T., Clark, G.T. et al. Use of sodium hyaluronate in treating temporomandibular joint disorders: A randomized, doubleblind, placebo-controlled clinical trial. J Oral Maxillofac Surg 1993, 51: 232-42.
68. Hamano, T., Horimoto, K., Lee, M., Komemushi, S. Sodium hyaluronate eyedrops enhance tear film stability. Jpn J Ophthalmol 1996, 40: 62-5.
69. Horwath, J., Schmut, O., Farr, C., Faulborn, J. Treatment of the dry eye syndrome with hyaluronate eye drops. Spektrum Augenheilkd 1995, 9: 215-7.
70. Bartold, P.M., Page, R.C. Hyaluronic acid synthesized by fibroblasts cultured from normal and chronically inflammed human gingivae. Coll Relat Res 1986, 6: 365-77.
71. Bartold, P.M., Page, R.C. The effect of chronic inflammation on gingival connective tissue proteoglycans and hyaluronic acid. J Oral Pathol 1986, 15: 367-74.
72. Bartold, P.M. Interleukin-1 stimulates proteoglycan and hyaluronic acid production by human gingival fibroblasts in vitro. Aust Dent J 1988, 33: 467-75.
73. Dahllöf, G., Modèer, T., Reinholt, F.P., Wiksktröm, B., Hjerpe, A. Proteoglycans and glycosaminoglycans in phenytoin-induced gingival overgrowth. J Periodontal Res 1986, 21: 13-21.
74. Suresh, R., Puvanakrishnan, R., Dhar, S.C. Alterations in human gingival glycosaminoglycan pattern in inflammation and in phenytoin induced overgrowth. Mol Cell Biochem 1992, 115: 149-54.
75. Berrone, S., Gallesio, G., De Gioanni, P.P., Tofti, F. Impiedo dell'acido ialuronico in odontostomatologia e in chirurgia maxillo-facciale. Revisione della letteratura e prospettive future. Stomat Lomb 1992, 4: 227-34.
76. Sasaki, T., Kawamata-Kido, H. Providing an environment for reparative dentine induction in amputated rat molar pulp by high molecular-weight hyaluronic acid. Arch Oral Biol 1997, 1995: 209-19.
77. Vangelisti, R., Pagnacco, O., Erra, C. L'acido ialuronico nel trattamento topico delle infiammazioni gengivali: Studio clinico preliminare. Attual Ter Int 1997, 3: 2-3.
78. Pagnacco, A., Vangelisti, R., Erra, C., Poma, A. Studio clinico in doppio cieco verso placebo di un nuovo gel gengivale a base di sodio ialuronato. Attua Ter Int 1997, 15(4): 1-7.
79. Haapasalo, M., Hannam, P., McBride, B.C., Uitto, V.J. Hyaluronan, a possible ligand mediating Treponema denticola binding to periodon-tal tissue. Oral Microbiol Immunol 1996, 11: 156-60.
80. Häkkinen, L., Oksala, O., Salo, T., Rahemtulla, F., Larjava, H. Immunohistochemical localisation of proteoglycans in human periodontum. J Histochem Cytochem 1993, 41: 1689-99.